These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22138434)

  • 61. Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception.
    Booker L; Naidu PS; Razdan RK; Mahadevan A; Lichtman AH
    Drug Alcohol Depend; 2009 Nov; 105(1-2):42-7. PubMed ID: 19679411
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Delta-9-tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB(1) receptors in the least shrew.
    Darmani NA
    Pharmacol Biochem Behav; 2001; 69(1-2):239-49. PubMed ID: 11420092
    [TBL] [Abstract][Full Text] [Related]  

  • 63. 3-Substituted pyrazole analogs of the cannabinoid type 1 (CB₁) receptor antagonist rimonabant: cannabinoid agonist-like effects in mice via non-CB₁, non-CB₂ mechanism.
    Wiley JL; Selley DE; Wang P; Kottani R; Gadthula S; Mahadeven A
    J Pharmacol Exp Ther; 2012 Feb; 340(2):433-44. PubMed ID: 22085649
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hyperlocomotion and paw tremors are two highly quantifiable signs of SR141716-precipitated withdrawal from delta9-tetrahydrocannabinol in C57BL/6 mice.
    Huang P; Liu-Chen LY; Unterwald EM; Cowan A
    Neurosci Lett; 2009 Nov; 465(1):66-70. PubMed ID: 19733208
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Discriminative stimulus properties of delta9-tetrahydrocannabinol (THC) in C57Bl/6J mice.
    Vann RE; Warner JA; Bushell K; Huffman JW; Martin BR; Wiley JL
    Eur J Pharmacol; 2009 Aug; 615(1-3):102-7. PubMed ID: 19470387
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.
    González S; Fernández-Ruiz J; Di Marzo V; Hernández M; Arévalo C; Nicanor C; Cascio MG; Ambrosio E; Ramos JA
    Drug Alcohol Depend; 2004 May; 74(2):159-70. PubMed ID: 15099659
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics.
    Fernández-Ruiz JJ; Muñoz RM; Romero J; Villanua MA; Makriyannis A; Ramos JA
    Biochem Pharmacol; 1997 Jun; 53(12):1919-27. PubMed ID: 9256167
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinically Relevant Pharmacological Strategies That Reverse MDMA-Induced Brain Hyperthermia Potentiated by Social Interaction.
    Kiyatkin EA; Ren S; Wakabayashi KT; Baumann MH; Shaham Y
    Neuropsychopharmacology; 2016 Jan; 41(2):549-59. PubMed ID: 26105141
    [TBL] [Abstract][Full Text] [Related]  

  • 69. MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats.
    Clemens KJ; Cornish JL; Li KM; Hunt GE; McGregor IS
    Neuropharmacology; 2005 Aug; 49(2):195-207. PubMed ID: 15993443
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Long-term voluntary consumption of MDMA and THC in rats is modified by individual and situational factors.
    Reinhard C; Wolffgramm J
    Addict Biol; 2006 Jun; 11(2):131-44. PubMed ID: 16800826
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Critical role of peripheral vasoconstriction in fatal brain hyperthermia induced by MDMA (Ecstasy) under conditions that mimic human drug use.
    Kiyatkin EA; Kim AH; Wakabayashi KT; Baumann MH; Shaham Y
    J Neurosci; 2014 Jun; 34(23):7754-62. PubMed ID: 24899699
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cannabinoid agonists differentially substitute for the discriminative stimulus effects of Delta(9)-tetrahydrocannabinol in C57BL/6J mice.
    McMahon LR; Ginsburg BC; Lamb RJ
    Psychopharmacology (Berl); 2008 Jul; 198(4):487-95. PubMed ID: 17673980
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of ambient temperature on hyperthermia and hyperkinesis induced by 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") in rats.
    Dafters RI
    Psychopharmacology (Berl); 1994 Apr; 114(3):505-8. PubMed ID: 7855209
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.
    Smith PA; Selley DE; Sim-Selley LJ; Welch SP
    Eur J Pharmacol; 2007 Oct; 571(2-3):129-37. PubMed ID: 17603035
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of chronic Delta(9)-tetrahydrocannabinol treatment on hippocampal extracellular acetylcholine concentration and alternation performance in the T-maze.
    Nava F; Carta G; Colombo G; Gessa GL
    Neuropharmacology; 2001 Sep; 41(3):392-9. PubMed ID: 11522331
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
    Darmani NA; Johnson JC
    Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Novel 3-substituted rimonabant analogues lack Δ(9) -tetrahydrocannabinol-like abuse-related behavioural effects in mice.
    Walentiny D; Vann R; Mahadevan A; Kottani R; Gujjar R; Wiley J
    Br J Pharmacol; 2013 May; 169(1):10-20. PubMed ID: 23297801
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys.
    Schindler CW; Redhi GH; Vemuri K; Makriyannis A; Le Foll B; Bergman J; Goldberg SR; Justinova Z
    Neuropsychopharmacology; 2016 Aug; 41(9):2283-93. PubMed ID: 26888056
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Differences in the relative potency of SR 141716A and AM 251 as antagonists of various in vivo effects of cannabinoid agonists in C57BL/6J mice.
    McMahon LR; Koek W
    Eur J Pharmacol; 2007 Aug; 569(1-2):70-6. PubMed ID: 17553486
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Brain hyperthermia induced by MDMA (ecstasy): modulation by environmental conditions.
    Brown PL; Kiyatkin EA
    Eur J Neurosci; 2004 Jul; 20(1):51-8. PubMed ID: 15245478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.